Table 2.
Sample Size (n) |
Sensitivity / Specificity |
Sample Classification (N) | |||
---|---|---|---|---|---|
Normal | Peri-Tumor | Tumor | |||
Training Set | |||||
Normal | 10 | 100% / 90.9% | 10 | 0 | 0 |
Peri-tumor | 55 | 96.4% / 94.6% | 1 | 53 | 1 |
Tumor | 55 | 94.5% / 98.1% | 0 | 3 | 52 |
Blind validation Set | |||||
Peri-tumor | 25 | 76.0% / 90.4% | 1 | 19 | 5 |
Tumor | 25 | 88.0% / 81.5% | 0 | 3 | 22 |
Overall | |||||
Normal | 10 | 100% / 90.9% | 10 | 0 | 0 |
Peri-tumor | 80 | 90.0% / 83% | 2 | 72 | 6 |
Tumor | 80 | 92.5% / 92.5% | 0 | 6 | 74 |
Note: “Peri-tumor” is non-malignant liver tissue adjacent to the tumor; “Normal” is residual liver graft tissue.